Stockscreener 앱 받기
3.105
2.58%
-0.075
전일 마감가:
$3.18
열려 있는:
$3.14
하루 거래량:
56,535
Relative Volume:
0.10
시가총액:
$222.73M
수익:
$115.02M
순이익/손실:
$-68.73M
주가수익비율:
-3.3184
EPS:
-0.9357
순현금흐름:
$-53.22M
1주 성능:
+3.78%
1개월 성능:
+10.64%
6개월 성능:
-6.41%
1년 성능:
-10.98%
1일 변동 폭
$3.02
$3.175
1주일 범위
$2.88
$3.23
52주 변동 폭
$2.08
$4.22
Orasure Technologies Inc Stock (OSUR) Company Profile
명칭
Orasure Technologies Inc
전화
(503) 641-6115
주소
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.105 | 228.11M | 115.02M | -68.73M | -53.22M | -0.9357 |
|
ISRG
Intuitive Surgical Inc
|
484.96 | 175.03B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
161.87 | 46.42B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.27 | 39.37B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
235.66 | 34.98B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.35 | 34.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-03 | 재개 | Evercore ISI | In-line |
| 2021-09-22 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | 개시 | Evercore ISI | Outperform |
| 2020-08-10 | 개시 | Citigroup | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
| 2020-08-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | 개시 | Lake Street | Buy |
| 2020-04-21 | 재개 | Stephens | Equal-Weight |
| 2018-10-23 | 재개 | Raymond James | Mkt Perform |
| 2018-07-16 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-02-09 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | 재확인 | Mizuho | Buy |
| 2015-05-07 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | 재확인 | Mizuho | Buy |
| 2014-06-12 | 재확인 | Canaccord Genuity | Buy |
| 2014-06-11 | 재확인 | Mizuho | Buy |
| 2012-12-21 | 개시 | Mizuho | Buy |
| 2012-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Orasure Technologies Inc 주식(OSUR)의 최신 뉴스
Aug Fed Impact: Is OraSure Technologies Inc attractive for institutional investorsExit Point & Daily Volume Surge Signals - baoquankhu1.vn
Former VA head departs OraSure board - WFMZ.com
OraSure Technologies 2025 Annual Report: Diagnostic Products, Genomic Solutions, and Global Expansion - Minichart
Momentum Shift: Is OraSure Technologies Inc being accumulated by smart moneyWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn
Fed Meeting: Why is OraSure Technologies Inc stock going upJuly 2025 Gainers & Long Hold Capital Preservation Plans - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above 200 Day Moving AverageHere's What Happened - MarketBeat
OraSure Technologies Developments Capture Healthcare Market Interest - Kalkine Media
OraSure Technologies Announces Resignation of Board Member Shulkin - TipRanks
OraSure (OSUR) CEO gets major stock awards, shares withheld for taxes - Stock Titan
OraSure Technologies, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OSUR) 2026-03-03 - Seeking Alpha
Healthy Trucking Association Launches Hepatitis C Initiative - Heavy Duty Trucking
OSUR Should I Buy - Intellectia AI
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies (OSUR) Loss Worsens To US$0.27 EPS And Tests Margin Recovery Narrative - simplywall.st
OraSure Technologies, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OraSure Announces Fourth Quarter 2025 Financial Results - National Today
OraSure Technologies Q4 Earnings Call Highlights - MarketBeat
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights - GuruFocus
OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches - MSN
Earnings Call Summary | OraSure Technologies(OSUR.US) Q4 2025 Earnings Conference - 富途牛牛
OraSure: Fourth Quarter Financial Results Overview - Bitget
OraSure Technologies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
OraSure closes the book on 'transition year' of 2025 - WFMZ.com
Earnings call transcript: OraSure Technologies Q4 2025 earnings fall short of revenue expectations - Investing.com Australia
OraSure Technologies (NASDAQ:OSUR) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
OraSure: Q4 Earnings Snapshot - Barchart.com
OraSure Technologies (OSUR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
OraSure Highlights 2025 Results and 2026 Growth Outlook - TipRanks
Revenue drops as OraSure (NASDAQ: OSUR) posts deeper 2025 loss - Stock Titan
Tranche Update on OraSure Technologies, Inc.'s Equity Buyback Plan announced on March 24, 2025. - marketscreener.com
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies (OSUR) Expected to Announce Earnings on Wednesday - MarketBeat
Aug Technicals: Can Fulgent Genetics Inc stock outperform in a bear marketQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
OraSure’s HIV self-test receives Health Canada license By Investing.com - Investing.com Nigeria
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
OraSure makes job cuts as it ‘rebalances’ for future growth - Lehigh Valley Business
How sensitive is OraSure Technologies Inc. to inflationJuly 2025 Setups & Verified Chart Pattern Signals - mfd.ru
Will OraSure Technologies Inc. stock benefit from automationJuly 2025 Final Week & Weekly High Potential Alerts - mfd.ru
Oral HIV self-test approved for sale in Canada - CBC
Oral HIV self-test can now be sold in Canada in ‘key’ move - Global News
Canada’s first oral HIV self-test has been approved for sale - The Globe and Mail
OraSure (OSUR) Gains Health Canada Approval for OraQuick HIV Sel - GuruFocus
Orasure to Launch Oraquick?? Hiv Self-Test in Canada - marketscreener.com
OraSure’s HIV self-test receives Health Canada license - Investing.com
OraSure to Launch OraQuick™ HIV Self-Test in Canada - ChartMill
At-home oral HIV self-test approved for sale in Canada - Toronto Sun
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th - The Manila Times
OraSure Technologies, Inc. Schedules Fourth Quarter 2025 Earnings Conference Call for February 25, 2026 - Quiver Quantitative
OraSure trimming global workforce, including here in Lehigh Valley - WFMZ.com
Treasury Yields: How does OraSure Technologies Inc perform in inflationary periodsJuly 2025 Spike Watch & Smart Allocation Stock Reports - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Orasure Technologies Inc (OSUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Orasure Technologies Inc 주식 (OSUR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Gagliano Nancy J | Director |
Nov 28 '25 |
Buy |
2.37 |
2,100 |
4,982 |
160,254 |
0.67%
자본화:
|
볼륨(24시간):